About

Who we are

We are a multidisciplinary team of industrial experts, bringing together over 40 years of combined experience in medical device and drug development across leading medical device and pharmaceutical companies.

With a proven track record in global clinical trial design, execution and regulatory submissions, our team has contributed to the successful market launches across a wide range of novel medical device technologies—from in vitro diagnostic devices (IVDs) to advanced digital health solutions. These include AI-assisted clinical decision support systems (CDSS), digital biomarkers, and software as a medical devices (SaMD).

Furthermore, our team brings in-depth expertise across the full spectrum of pharmaceutical clinical trials, from Phase I to Phase IV. With a strong domain knowledge in regulatory strategy, trial feasibility, and data management, we understand the complexities of drug development at every stage. We have supported study teams of all sizes in achieving efficient trial execution and ensuring compliance with global regulatory standards.

Driving smarter, faster clinical trials with deep expertise and end-to-end, AI-enabled digital solutions

What we do

Having spent years of hands-on experience in pharma companies managing global clinical operations, the founders saw firsthand how inadequate study design, slow recruitment, and inefficient trial management systems drive up costs and delay patients’ access to critical treatments.

With no existing solutions addressing these pain points effectively, the founders took the initiative to develop AI-enabled SaaS solutions to streamline trial operations efficiently.

At the core, we’re passionate about clinical innovation so that life-changing treatments can reach those who need them faster.